Decision Diagnostics Stock Buy Hold or Sell Recommendation
| DECN Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Decision Diagnostics is 'Strong Sell'. The recommendation algorithm takes into account all of Decision Diagnostics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Decision Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide. In addition, we conduct extensive research on individual companies such as Decision and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Decision |
Execute Decision Diagnostics Buy or Sell Advice
The Decision recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Decision Diagnostics. Macroaxis does not own or have any residual interests in Decision Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Decision Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Decision Diagnostics Trading Alerts and Improvement Suggestions
| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 462.23 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Decision Diagnostics has a frail financial position based on the latest SEC disclosures |
Decision Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Decision Diagnostics or Health Care Technology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Decision Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Decision stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Decision Diagnostics Volatility Alert
At this time Decision Diagnostics exhibits very low volatility. Decision Diagnostics appears to be a penny stock. Although Decision Diagnostics may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Decision Diagnostics or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Decision instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Decision Diagnostics Fundamentals Vs Peers
Comparing Decision Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Decision Diagnostics' direct or indirect competition across all of the common fundamentals between Decision Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Decision Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Decision Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Decision Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Decision Diagnostics to competition |
| Fundamentals | Decision Diagnostics | Peer Average |
| Return On Equity | -81.61 | -0.31 |
| Return On Asset | -0.21 | -0.14 |
| Operating Margin | (0.95) % | (5.51) % |
| Current Valuation | 3.06 M | 16.62 B |
| Shares Outstanding | 357.87 M | 571.82 M |
| Price To Earning | (0.33) X | 28.72 X |
| Price To Book | 2.72 X | 9.51 X |
| Price To Sales | 0.02 X | 11.42 X |
| Revenue | 1.98 M | 9.43 B |
| Gross Profit | 462.23 K | 27.38 B |
| EBITDA | (2.41 M) | 3.9 B |
| Net Income | (29.67 M) | 570.98 M |
| Cash And Equivalents | 210.85 K | 2.7 B |
| Total Debt | 2.93 M | 5.32 B |
| Debt To Equity | 9.05 % | 48.70 % |
| Current Ratio | 0.25 X | 2.16 X |
| Cash Flow From Operations | (1.4 M) | 971.22 M |
| Earnings Per Share | (0.02) X | 3.12 X |
| Number Of Employees | 6 | 18.84 K |
| Beta | -1.78 | -0.15 |
| Market Capitalization | 35.79 K | 19.03 B |
| Total Asset | 5.65 M | 29.47 B |
| Retained Earnings | (79.4 M) | 9.33 B |
| Working Capital | (3.3 M) | 1.48 B |
| Current Asset | 4.3 M | 9.34 B |
| Current Liabilities | 3.06 M | 7.9 B |
| Net Asset | 5.65 M |
Decision Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Decision . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Decision Diagnostics Buy or Sell Advice
When is the right time to buy or sell Decision Diagnostics? Buying financial instruments such as Decision Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Decision Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Medical Equipment Thematic Idea Now
Medical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Decision Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.